###begin article-title 0
Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1
###end article-title 0
###begin p 1
###xml 108 111 <span type="species:ncbi:9606">man</span>
To whom correspondence should be addressed. Tel: +44 161 275 5978; Fax: +44 161 275 5082; Email: paul.shore@man.ac.uk
###end p 1
###begin p 2
###xml 783 788 783 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">obf-1</italic>
###xml 788 791 788 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
###xml 217 222 <span type="species:ncbi:10090">mouse</span>
###xml 257 262 <span type="species:ncbi:9606">human</span>
###xml 282 287 <span type="species:ncbi:10090">mouse</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
###xml 855 860 <span type="species:ncbi:10090">mouse</span>
The POU domain transcription factor, Oct-2, is essential for the B cell-specific expression of CD36 in mouse B cells. In order to determine how Oct-2 mediates expression of CD36 in B cells, we cloned and analysed the mouse CD36 promoter. In contrast to the human CD36 promoter, the mouse promoter contains a consensus octamer element of the type ATGCTAAT. This octamer element can be bound by either Oct-1 or Oct-2 but requires the expression of Oct-2 to activate transcription in B cells. Mutation of the octamer element renders the CD36 promoter refractory to activation by Oct-2. Furthermore, we demonstrate that the CD36 octamer element does not support recruitment of the B cell-specific co-activator OBF-1 and that CD36 expression is unaffected in primary B cells derived from obf-1-/- mice. We conclude that Oct-2 activates CD36 gene expression in mouse B cells via the octamer element in the promoter. Our data also demonstrate that CD36 is the first example of an Oct-2-dependent gene whose expression in B cells is independent of OBF-1. These findings support the notion that Oct-2 regulates gene transcription by both OBF-1-dependent and -independent mechanisms.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c1">1</xref>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c3">3</xref>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">snRNA</italic>
###xml 417 420 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2B</italic>
###xml 480 482 480 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ig</italic>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c1">1</xref>
###xml 505 506 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c4">4</xref>
###xml 658 659 658 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c1">1</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c4">4</xref>
###xml 755 756 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c2">2</xref>
###xml 761 762 761 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c3">3</xref>
###xml 880 881 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 904 905 904 905 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
The octamer motif ATGC(A/T)AAT is a conserved DNA element found in the promoters and enhancers of a diverse range of genes (reviewed in 1-3). Genes that are transcriptionally regulated by octamer motifs can be either ubiquitously expressed or cell type specific. For example, the octamer motif is required for the ubiquitous expression of the small nuclear RNA (snRNA) genes, the cell cycle regulation of the histone H2B gene and the B cell-specific expression of immunoglobulin (Ig) genes (reviewed in 1-4). The ability of the octamer motif to differentially regulate transcription is determined by the octamer binding proteins Oct-1 and Oct-2 (reviewed in 1-4). Oct-1 and Oct-2 are members of the POU domain family of transcription factors (reviewed in 2 and 3). The POU domain is a conserved bipartite DNA-binding domain consisting of two subdomains: a POU-specific domain (POUS) and a homedomain (POUH), separated by a flexible linker.
###end p 4
###begin p 5
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c1">1</xref>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c4">4</xref>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c6">6</xref>
###xml 393 398 393 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">snRNA</italic>
###xml 481 482 481 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c7">7</xref>
###xml 528 530 528 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ig</italic>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c8">8</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c12">12</xref>
###xml 771 772 771 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c9">9</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c16">16</xref>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c13">13</xref>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c16">16</xref>
###xml 967 972 967 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">obf-1</italic>
###xml 972 975 972 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 1107 1109 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c17">17</xref>
###xml 1110 1112 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c18">18</xref>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
Oct-1 is ubiquitously expressed whereas Oct-2 expression is restricted to a small number of cell types, including B cells (reviewed in 1; 4-6). The differential expression of some octamer-dependent genes can be explained partly by the interaction between octamer-binding proteins and promoter-selective co-activators that are themselves either cell type specific or ubiquitous. In the case of snRNA genes, ubiquitous expression is achieved by the association of Oct-1 with the SNAPc complex (7). B cell-restricted expression of Ig genes requires association of the B cell-specific co-activator OBF-1/OCA-B/Bob-1 (referred to here as OBF-1) with either Oct-1 or Oct-2 (8-12). Interaction of OBF-1 with Oct-1 or Oct-2 is mediated by direct contacts with their POU domains (9-16). However, the formation of a stable complex is also determined by the specific sequence of the octamer element, suggesting that OBF-1 targets a subset of octamer-regulated genes (13-16). In obf-1-/- mice the two most obvious defects are the absence of germinal centres and a profound deficiency in serum Ig of secondary isotypes (17,18).
###end p 5
###begin p 6
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c19">19</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c20">20</xref>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
The presence of Oct-1 in cell types that do not express Oct-2 suggests that Oct-1 determines the transcriptional activation of octamer-dependent genes in these cells. However, in B cells, where both Oct-1 and Oct-2 are present, it is not clear how each of these transcription factors targets individual octamer-dependent genes. Analysis of B cells in Oct-2-deficient mice demonstrated that whilst Oct-2 was dispensable for the antigen-independent phase of B cell differentiation, it was required for antigen-dependent differentiation and proliferation (19,20). These observations suggest that there are genes whose transcription cannot be activated by Oct-1 but which are critically dependent upon Oct-2. Analysis of the regulatory elements in Oct-2-specific genes should therefore reveal how Oct-2 can regulate genes that Oct-1 cannot.
###end p 6
###begin p 7
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c21">21</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c22">22</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c21">21</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c21">21</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c23">23</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c24">24</xref>
###xml 952 959 952 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crisp-3</italic>
###xml 964 968 964 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blr1</italic>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c25">25</xref>
###xml 1006 1008 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c26">26</xref>
###xml 1049 1056 1049 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crisp-3</italic>
###xml 1110 1117 1110 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crisp-3</italic>
###xml 1226 1230 1226 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blr1</italic>
###xml 1237 1239 1237 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c25">25</xref>
###xml 1240 1242 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c26">26</xref>
###xml 145 151 <span type="species:ncbi:9606">humans</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 342 347 <span type="species:ncbi:10090">mouse</span>
###xml 502 507 <span type="species:ncbi:9606">human</span>
###xml 600 605 <span type="species:ncbi:9606">human</span>
###xml 691 696 <span type="species:ncbi:10090">mouse</span>
###xml 807 812 <span type="species:ncbi:10090">mouse</span>
The first bona fide Oct-2 target gene to be identified encodes the scavenger receptor, CD36. CD36 is expressed in a number of cell types in both humans and mice, including monocytes/macrophages, platelets and adipocytes (21,22). However, CD36 expression in B cells appears to be specific to mice (21). Nevertheless, the expression of CD36 in mouse B cells is critically dependent upon Oct-2, and is therefore an ideal model to investigate Oct-2-specific transcriptional regulation in B cells (21). The human CD36 promoter has been characterized and, consistent with the lack of expression of CD36 in human B cells, does not contain recognisable octamer elements (23,24). The promoter of the mouse CD36 gene has not been characterised previously and the mechanism by which Oct-2 regulates CD36 expression in mouse B cells remains to be elucidated. Moreover, of the small number of additional Oct-2 target genes that have since been identified, only the crisp-3 and blr1 promoters have been investigated (25,26). Two low-affinity octamer sites in the crisp-3 promoter mediate Oct-2-specific transcription of the crisp-3 gene, whereas a single non-consensus octamer mediates the Oct-2-dependent transcriptional activation of the blr1 gene (25,26).
###end p 7
###begin p 8
###xml 632 637 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">obf-1</italic>
###xml 637 640 637 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 704 709 <span type="species:ncbi:10090">mouse</span>
In order to determine how Oct-2 mediates expression of CD36 in B cells, we cloned and analysed the mouse CD36 promoter. In contrast to the human CD36 promoter, the mouse promoter contains a consensus octamer element of the type ATGCTAAT. This octamer element can be bound by either Oct-1 or Oct-2 but requires the expression of Oct-2 to activate transcription in B cells. Mutation of the octamer element renders the CD36 promoter refractory to activation by Oct-2. Furthermore, we demonstrate that the CD36 octamer element does not support recruitment of OBF-1 and that CD36 expression is unaffected in primary B cells derived from obf-1-/- mice. We conclude that Oct-2 activates CD36 gene expression in mouse B cells via the octamer element in the promoter. Our data also demonstrate that CD36 is the first example of an Oct-2-dependent gene whose expression in B cells is independent of OBF-1. These findings support the notion that Oct-2 regulates gene transcription by both OBF-1-dependent and -independent mechanisms.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
Cloning of the mouse CD36 promoter
###end title 10
###begin p 11
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c27">27</xref>
###xml 676 678 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c27">27</xref>
###xml 872 874 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c28">28</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
###xml 655 660 <span type="species:ncbi:9606">human</span>
###xml 780 785 <span type="species:ncbi:10090">mouse</span>
###xml 1052 1057 <span type="species:ncbi:10090">mouse</span>
The mouse CD36 promoter sequence was cloned using the mouse Promoter Finder DNA Walking kit according to the manufacturer's instructions (Clontech). PCRs were carried out using CD36-specific primers corresponding to the 5' region of the published cDNA sequence (27) and the supplied adapter primers. The sequences of the gene-specific primers were CD36GSP1, 5'-ACCATCCACCAGTTGCTCCACACATTTCAG-3' and CD36GSP2, 5'-GGCAGCTGTGAAGAAGAAAAAGTCCTCAGT-3'. A single approximately600 bp PCR product from the secondary reactions was ligated directly into the T-vector pT7blue (Novagen). Nine of the clones were sequenced and found to have identity with the published human CD36 promoter (27). One of these clones was subsequently used as a probe to obtain larger genomic clones from a 129/Sv mouse genomic library in Lambda FIX II (Stratagene) using standard hybridisation protocols (28). A single positive genomic clone of approximately19 kb was obtained and partially sequenced by the dideoxy chain termination method. The presence of DNA matching the published mouse CD36 cDNA was confirmed by a BLAST search of the NCBI sequence database. DNA sequence alignment was done using Align Plus 4 software.
###end p 11
###begin title 12
Plasmid constructs
###end title 12
###begin p 13
###xml 23 26 11 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 148 149 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f1">1</xref>
###xml 514 517 490 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sac</italic>
###xml 523 526 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 688 690 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c29">29</xref>
###xml 980 983 956 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sac</italic>
###xml 989 992 965 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 1088 1090 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c30">30</xref>
###xml 1233 1236 1209 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 1243 1246 1219 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
###xml 118 123 <span type="species:ncbi:9606">human</span>
An approximately2.6 kb EcoRI fragment from the mouse CD36 genomic clone that contains the region with homology to the human CD36 promoter (see Fig. 1), and extends approximately2.3 kb further upstream, was ligated into pBluescript II KS (Stratagene) to produce pBS2.6CD36. The CD36 promoter reporter plasmid, pGLCD36, was constructed by PCR amplification of the region spanning -615 to +20 bp (primers 5'-GATCGAGCTCTATAAGCATATCACCATC-3'; 5'-GATCAAGCTTGAATTCCTCACTACTTATGT-3'). The PCR product was ligated into the SacI and HindIII sites of pGL2-Basic (Promega) to produce the plasmid pGLCD36. The octamer site in pGLCD36 was mutated using a two-step PCR protocol as described previously (29). The octamer was mutated using the primers 5'-GATCGAGCTCTATAAGCATATCACCATC-3' and the mutagenic primer 5'-TTAAAAAATTCAATGTCAGCGGCGAATTTGTGGTAGGTTGCCAA-3' in the first round PCR and 5'-GATCCAAGCTTGAATTCCTCACTACTTATGT-3' in the second round. The subsequent PCR product was ligated into the SacI and HindIII sites of pGL2-Basic to produce pGLCD36mOct. The sequence encoding the POU domain of Oct-2 (30) was amplified by PCR using the primers 5'-GATCGGATCCCCGGAGGAGCCCAGCGATCTG-3' and 5'-GATCGAATTCATCACGCACTGCAAGGGTTGAT-3' and ligated into the BamHI and EcoRI sites of pGEX-2TK (Pharmacia Biotech) to produce the plasmid pGEXPOU-2, which encodes the POU domain of Oct-2. The sequences of constructs generated by PCR were verified by automated dideoxy sequencing.
###end p 13
###begin title 14
Proteins
###end title 14
###begin p 15
###xml 41 57 41 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c31">31</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c32">32</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c10">10</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c33">33</xref>
###xml 41 57 <span type="species:ncbi:562">Escherichia coli</span>
###xml 196 199 <span type="species:ncbi:9860">Elk</span>
###xml 303 309 <span type="species:ncbi:9986">rabbit</span>
The POU domain of Oct-2 was expressed in Escherichia coli as a fusion protein with glutathione S-transferase from the plasmid pGEXPOU-2. The proteins were purified as described previously for the Elk-1 ETS domain (31). Oct-1, Oct-2 and OBF-1 were produced by coupled transcription-translation using TNT rabbit reticulocyte lysates (Promega) from plasmids pHA-Oct-1, pHA-Oct-2 (32) and pCATCH-Bob1 (10), respectively. Nuclear extracts from cell lines were prepared as described previously (33).
###end p 15
###begin title 16
Cell culture, cell transfection and reporter assays
###end title 16
###begin p 17
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c21">21</xref>
###xml 222 224 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c34">34</xref>
###xml 318 320 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c21">21</xref>
B cell lines Abl1.1, Abl/Oct-2-ER (kindly provided by T. Wirth, Universitat Wurzburg, Germany) and WEHI231 were grown in standard conditions (21) and transfected with 10-20 microg of plasmid using the DEAE/Dextran method (34). Abl1.1 and Abl/Oct-2-ER cells were stimulated with beta-estradiol as described previously (21).
###end p 17
###begin p 18
###xml 750 752 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c27">27</xref>
###xml 753 755 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c28">28</xref>
For luciferase assays, cells were harvested 24 h after transfection, lysed with reporter lysis buffer and the enzyme activity determined using the luciferase assay system according to the manufacturer's recommendations (Promega). Transfection of the B cell lines was performed in duplicate or triplicate and normalised for total cellular protein using the Bradford assay reagent (Bio-Rad). beta-Estradiol-stimulated and -unstimulated cultures were derived from the same transfection by dividing the culture into two, 8 h after transfection. An equal amount of protein from each culture was used in the luciferase assay 18 h after stimulation. Northern blot analysis was performed by hybridisation using the CD36 cDNA according to standard protocols (27,28).
###end p 18
###begin title 19
Gel retardation assays
###end title 19
###begin p 20
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c33">33</xref>
###xml 141 143 137 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 160 162 152 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 248 250 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c28">28</xref>
###xml 479 481 471 473 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CG</bold>
###xml 483 484 475 476 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 531 532 523 524 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 534 536 526 528 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CG</bold>
###xml 687 689 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c13">13</xref>
###xml 693 694 685 686 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 770 772 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c35">35</xref>
Gel retardation assays were performed as described previously (33). Synthetic oligonucleotides were radiolabelled by incorporation of [alpha-32P]dATP or [alpha-32P]dCTP using the Klenow fragment of DNA polymerase I according to standard protocols (28). The following pairs of complimentary oligonucleotides were used to make radiolabelled probes: CD36, 5'-GATCAATTCAATGTCAGATGCTAATTTGTGGTAGGT-TG-3' and 5'-GATCCAACCTACCACAAATTAGCATCTGACATTGAATT-3'; CD36mOct, 5'-GATCAATTCAATGTCAGCGGCGAATTTGTGGTAGGTTG-3' and 5'-GATCCAACCTACCACAAATTCGCCGCTGACATTGAATT-3'; CD36 Oct, 5'-CTAGCAAATTAGCATCTG-3' and 5'-CTAGCAGATGCTAATTTG-3'; IgK Oct, 5'-CAGTGGGTATGCAAATTATT-3' and 5'-CAGTAATAATTTGCATACCC-3' (13); VHOct, 5'-GATCCTTAATAATTTGCATACCCTCA-3' and 5'-GATCTGAGGGTATGCAAATTATTAAG-3' (35).
###end p 20
###begin p 21
All DNA-binding sites were purified on 10% non-denaturing polyacrylamide gels. In standard reactions, proteins and labelled DNA were incubated in a total of 10 or 12 microl volumes. Reactions were incubated at room temperature for 20 min prior to loading onto a 5% non-denaturing polyacrylamide gel. Gels were fixed, dried and visualised by autoradiography.
###end p 21
###begin title 22
RT-PCR
###end title 22
###begin p 23
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">obf-1</italic>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c18">18</xref>
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 155 158 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c19">19</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c20">20</xref>
###xml 296 297 292 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1338 1340 1301 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c28">28</xref>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
Spleen cell suspensions were prepared from mice bearing mutations in the obf-1 gene (18), or from RAG-1-deficient mice reconstituted with oct-2+/+ or oct-2-/- fetal liver (19,20). The cells were cultured for 16 h in the presence of 10 microg/ml lipopolysaccharide (LPS), after which B cells (B220+) were harvested by sorting on a MoFlo cell sorter (Cytomation, Inc.). Cytoplasmic RNA was prepared and first-strand cDNA synthesised according to the manufacturer's instructions (Pharmacia Biotech). Template cDNAs were titrated using serial dilutions and a beta-actin-specific PCR (primers 5'-GTGGGCCGCTCTAGGCACCAA-3'; 5'-CTCTTTGATGTCACGCACGATTTC-3'), with 25 cycles (94degreesC for 1 min, 55degreesC for 1 min, 72degreesC for 1 min). Dilutions giving equivalent levels of beta-actin product were used in PCR assays for either CD36 (primers 5'-GGATCTGAAATCGACCTTAAAG-3'; 5'-TAGCTGGCTTGACCAATATGTT-3'), Oct-2 (primers 5'-CCCGGGCTGGGCTTCCTACACAG-3'; 5'-GTAGCTGGTCGGCTTTCCCGGGCT-3') or OBF-1 (primers 5'-CGGTGTTGACCTATGCTTCTCCACC-3'; 5'-GAGGGGCGCCTGGTGCTCGGGACCC-3'). The CD36 PCR was done using the beta-actin programme. The annealing temperature for the Oct-2 and OBF-1 reactions was 70degreesC. Reaction products were resolved on agarose gels, transferred to filters and probed with the corresponding cDNAs according to standard protocols (28).
###end p 23
###begin title 24
5'-RACE
###end title 24
###begin p 25
###xml 599 600 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f1">1</xref>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
5'-RACE was performed using the SMART RACE cDNA amplification kit according to the protocol provided. The RNA was total RNA from LPS-stimulated splenocytes from C57BL/6 mice. The CD36 gene-specific primers were 5'-CCAGTTGCTCCACACATTTCAGAAGGCAGC-3' and 5'-CCTTTGAAAGGCTAGGAAACCATCCACCAGTTGC-3'. After the secondary PCR reaction, there was a single band on the gel of approximately150 bp. This was purified and ligated directly into pGEM-T Easy (Promega). Twelve clones were sequenced, and all revealed initiation sites at one of two positions; seven at the 5'-most A, and five at the 3'-most A (Fig. 1A).
###end p 25
###begin title 26
RESULTS
###end title 26
###begin title 27
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
Cloning of the mouse CD36 promoter
###end title 27
###begin p 28
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c21">21</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c27">27</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c23">23</xref>
###xml 912 913 900 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f1">1</xref>
###xml 1078 1079 1054 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f1">1</xref>
###xml 1210 1211 1186 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f1">1</xref>
###xml 119 124 <span type="species:ncbi:10090">mouse</span>
###xml 288 293 <span type="species:ncbi:10090">mouse</span>
###xml 485 490 <span type="species:ncbi:9606">human</span>
###xml 600 605 <span type="species:ncbi:10090">mouse</span>
###xml 886 891 <span type="species:ncbi:9606">human</span>
###xml 950 955 <span type="species:ncbi:10090">mouse</span>
The CD36 gene was identified as an Oct-2-regulated gene by subtractive cDNA cloning (21). However, the sequence of the mouse promoter has not been reported and the molecular basis of Oct-2-dependent CD36 expression has not been elucidated. We therefore used the published sequence of the mouse CD36 cDNA to design PCR primers to amplify genomic DNA upstream of the start of the known cDNA sequence (27). The sequence of this fragment was determined and found to have identity with the human CD36 promoter (23). This PCR-derived genomic DNA fragment was used as a probe to obtain larger clones from a mouse genomic library. Restriction mapping and partial sequencing revealed that a single clone contained a 19 kb genomic fragment extending approximately3.5 kb upstream from the cDNA sequence (data not shown). The region upstream of the cDNA was sequenced and aligned with the reported human CD36 promoter (Fig. 1A). The transcription start sites in mouse primary B cells were determined by 5'-RACE. After the secondary PCR, there was a single band of approximately150 bp (Fig. 1B). Cloning and sequencing of 12 individual 5'-RACE products revealed initiation sites at one of the two positions indicated (Fig. 1B).
###end p 28
###begin p 29
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f1">1</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c23">23</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c24">24</xref>
###xml 454 456 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c36">36</xref>
###xml 674 675 666 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f1">1</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
###xml 312 317 <span type="species:ncbi:9606">human</span>
###xml 542 547 <span type="species:ncbi:10090">mouse</span>
###xml 653 658 <span type="species:ncbi:9606">human</span>
###xml 748 753 <span type="species:ncbi:10090">mouse</span>
###xml 821 826 <span type="species:ncbi:10090">mouse</span>
The human and mouse sequences are 62% identical and several transcription factor-binding sites are conserved (Fig. 1A). The CAAT box is conserved and there is a TATA element appropriately positioned with respect to the transcription start sites. The two NF1 sites and the AML-1 site identified previously in the human promoter are also conserved (23,24). In addition, the DR-1 element, which binds the PPARgamma:RXRalpha complex, is perfectly conserved (36). The most striking difference is the presence of a consensus octamer element in the mouse promoter from -39 to -46 bp with respect to the 5'-most start site. This element is not conserved in the human promoter (Fig. 1). We therefore postulated that the presence of this octamer site in the mouse CD36 promoter determines the Oct-2-dependent expression of CD36 in mouse B cells.
###end p 29
###begin title 30
Oct-1 and Oct-2 bind to the CD36 promoter
###end title 30
###begin p 31
###xml 257 265 257 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f2">2</xref>
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f2">2</xref>
###xml 577 578 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f2">2</xref>
###xml 660 661 660 661 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 686 687 686 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f2">2</xref>
###xml 177 182 <span type="species:ncbi:10090">mouse</span>
Gel retardation assays were used to establish if Oct-1 or Oct-2 is able to bind to the CD36 octamer element. A double-stranded oligonucleotide encompassing -58 to -26 bp of the mouse CD36 promoter (CD36) was used as a probe. When incubated with recombinant in vitro translated Oct-1 or Oct-2, specific retarded complexes were observed (Fig. 2A). Both Oct-1 and Oct-2 formed complexes with the CD36 probe (Fig. 2A, lanes 2 and 3). When Oct-1 or Oct-2 was incubated with the analogous probe containing a mutated octamer site (CD36mOct), no specific complexes were observed (Fig. 2A, lanes 5 and 6). Binding of Oct-1 and Oct-2 to the consensus octamer sequence (VHOct) is also shown (Fig. 2A, lanes 8 and 9). The results demonstrate that both Oct-1 and Oct-2 are able to bind specifically to the octamer site in the CD36 promoter.
###end p 31
###begin p 32
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c1">1</xref>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c6">6</xref>
###xml 365 366 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f2">2</xref>
###xml 552 553 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f2">2</xref>
###xml 747 748 747 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f2">2</xref>
###xml 940 941 940 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f2">2</xref>
It is well established that when B cell nuclear extracts are incubated with an octamer element only complexes containing Oct-1 and Oct-2 are observed (1-6). We therefore performed a competition analysis to test the ability of the CD36 octamer (CD36 Oct) to abolish Oct-1- and Oct-2-specific complexes that form on the known octamer site from the IgK enhancer (Fig. 2B). When nuclear extracts from the B cell line WEHI231 were incubated with the IgK octamer in the absence of competitor DNA, both Oct-1- and Oct-2-specific complexes were observed (Fig. 2B, lane 1). In the presence of 100-fold molar excess of CD36 octamer both complexes were abolished. In contrast, both complexes were unaffected by the presence of mutated CD36 octamer DNA (Fig. 2B, lane 2). When the CD36 octamer DNA was used as a radiolabelled probe, two complexes were also observed that were completely abolished in the presence of excess IgK Oct competitor DNA (Fig. 2C, lanes 1 and 4). In contrast, competition with the mutated CD36 octamer DNA did not abolish binding. Taken together, the results clearly indicate that the octamer element in the CD36 promoter can be bound by endogenous Oct-1 and Oct-2.
###end p 32
###begin p 33
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f2">2</xref>
###xml 407 408 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f2">2</xref>
To establish unequivocally that endogenous Oct-2 is able to bind to the CD36 octamer, supershift analysis using an Oct-2-specific antibody was performed. In the presence of an Oct-2-specific antibody the lower mobility complex was abolished and an additional supershifted complex appeared (Fig. 2C, lane 6). Addition of serum alone did not abolish the Oct-2 complex nor produce a supershifted complex (Fig. 2C, lane 5). The results demonstrate clearly that endogenous Oct-2 can bind to the octamer element in the CD36 promoter.
###end p 33
###begin title 34
Oct-2 activates the CD36 promoter in B cells
###end title 34
###begin p 35
###xml 113 123 113 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luciferase</italic>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c21">21</xref>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 356 359 356 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c21">21</xref>
###xml 615 617 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c21">21</xref>
###xml 751 752 745 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f3">3</xref>
###xml 756 758 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c21">21</xref>
###xml 856 857 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f3">3</xref>
###xml 996 1001 987 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 1001 1004 992 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 1096 1097 1084 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f3">3</xref>
###xml 1221 1222 1206 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f3">3</xref>
###xml 1353 1354 1338 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f3">3</xref>
###xml 1635 1636 1617 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f4">4</xref>
###xml 345 350 <span type="species:ncbi:10090">mouse</span>
###xml 481 486 <span type="species:ncbi:9606">human</span>
To investigate the ability of Oct-2 to activate CD36 transcription the CD36 promoter was ligated upstream of the luciferase cDNA in the reporter plasmid pGL2-B to produce pGLCD36. In order to examine the role of Oct-2 in regulating the B cell expression of CD36 we used the pre-B cell line Abl/Oct-2-ER (21). This cell line was derived from the mouse oct-2-/- pre-B cell line Abl1.1 by stable transfection of a construct expressing Oct-2 fused to the hormone-binding domain of the human estrogen receptor (21). The specific effect of Oct-2 in a B cell can therefore be determined by the addition of beta-estradiol (21). Indeed, the endogenous transcription of the CD36 gene in this cell line is dependent upon beta-estradiol activation of Oct-2 (Fig. 3A) (21). Abl1.1 and Abl1.1/Oct-2-ER cells were transfected with the CD36 reporter plasmid pGLCD36 (Fig. 3B). After transfection, the cells were divided into two separate cultures and one was stimulated by the addition of beta-estradiol. In the oct-2-/- cells, addition of beta-estradiol had no effect on the activity of the CD36 promoter (Fig. 3B, Abl1.1). In contrast, addition of beta-estradiol to Abl/Oct-2-ER cells resulted in activation of the CD36 promoter (Fig. 3B, CD36). This is consistent with the activation of the endogenous CD36 gene as determined by northern blot analysis of mRNA (Fig. 3A). To determine that the activation was dependent upon the octamer site, we introduced specific mutations that abolish Oct-2 binding to the octamer. When the octamer sequence was mutated, addition of beta-estradiol almost totally blocked activation in Abl1.1/Oct-2-ER cells (Fig. 4, mOct). The results demonstrate clearly that the octamer site in the CD36 promoter mediates its Oct-2-dependent activation.
###end p 35
###begin title 36
Expression of CD36 in B cells requires Oct-2 but not OBF-1
###end title 36
###begin p 37
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c8">8</xref>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c16">16</xref>
###xml 256 257 256 257 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 315 316 315 316 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c13">13</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c14">14</xref>
###xml 407 408 407 408 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 620 625 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 625 628 625 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 840 841 840 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c2">2</xref>
###xml 966 967 966 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f5">5</xref>
###xml 1114 1115 1114 1115 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 1142 1143 1142 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f5">5</xref>
###xml 1254 1255 1254 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f5">5</xref>
###xml 1718 1723 1718 1723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 1723 1726 1723 1726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 1731 1736 1731 1736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">obf-1</italic>
###xml 1736 1739 1736 1739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 1751 1752 1751 1752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f5">5</xref>
###xml 1844 1849 1844 1849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 1849 1852 1849 1852 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 1915 1920 1915 1920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 1920 1923 1920 1923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 1936 1937 1936 1937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f5">5</xref>
###xml 1950 1952 1950 1952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c21">21</xref>
###xml 1989 1994 1989 1994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">obf-1</italic>
###xml 1994 1997 1994 1997 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 2101 2106 2101 2106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 2106 2109 2106 2109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 2166 2171 2166 2171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 2171 2174 2171 2174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 2222 2223 2222 2223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf265f5">5</xref>
###xml 2242 2247 2242 2247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OBF-1</italic>
###xml 2247 2250 2247 2250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 2256 2261 2256 2261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 2261 2264 2261 2264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 1544 1549 <span type="species:ncbi:10090">mouse</span>
###xml 1740 1744 <span type="species:ncbi:10090">mice</span>
OBF-1 activates transcription of octamer-containing promoters by binding directly to either Oct-1 or Oct-2 (8-16). Previous studies have shown that OBF-1 recruitment is dependent upon the presence of adenosine at position five in the octamer sequence (ATGCAAAT) and that octamers with thymine at this position (ATGCTAAT) do not form a ternary complex with OBF-1 (13,14). The CD36 octamer is of the type ATGCTAAT, suggesting that it cannot support recruitment of OBF-1. We have demonstrated that both Oct-1 and Oct-2 can bind to the CD36 octamer element but that no significant transcriptional activity was detectable in oct-2-/- B cells despite the high level of Oct-1 in these cells. Oct-1 is a weak activator of mRNA genes and therefore requires the presence of a co-activator to achieve efficient transcriptional activation (reviewed in 2). We therefore tested the ability of the CD36 octamer to form a ternary complex with OBF-1 in a gel retardation assay (Fig. 5A). The Oct-2 POU domain was used in order to clearly resolve the ternary complex. OBF-1 forms a ternary complex with the Oct-2 POU domain on the VHOct site (ATGCTAAAT) (Fig. 5A, lane 3). In contrast, when the CD36 octamer was used as a probe, OBF-1 did not form a ternary complex (Fig. 5A, lane 7). This result demonstrates that OBF-1 is excluded from the CD36 promoter and is unlikely to participate in Oct-2 transcriptional activation of the CD36 gene. To confirm that CD36 expression in B cells is independent of OBF-1 expression, we investigated the expression of CD36 in mouse primary B cells. The requirement for OBF-1 was investigated by examining the expression of CD36 by RT-PCR using RNA from mature primary B cells derived from wild-type, oct-2-/- and obf-1-/- mice (Fig. 5B). In agreement with a previous report, comparison of CD36 expression in the wild-type and oct-2-/- cells clearly demonstrated the lack of CD36 expression in the oct-2-/- cells (Fig. 5B, panel 2) (21). In contrast, CD36 is expressed in obf-1-/- splenic B cells to equivalent levels seen in the wild-type cells. Expression of OBF-1 is unaffected in oct-2-/- B cells, suggesting that the lack of CD36 expression in oct-2-/- cells is not due to the absence of OBF-1 (Fig. 5B panel 2; compare OBF-1-/- with oct-2-/-). Taken together the data demonstrate that the Oct-2-dependent expression of CD36 in B cells is independent of the co-activator OBF-1.
###end p 37
###begin title 38
DISCUSSION
###end title 38
###begin title 39
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
###xml 28 33 <span type="species:ncbi:9606">human</span>
Comparison of the mouse and human CD36 promoters
###end title 39
###begin p 40
###xml 384 386 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c36">36</xref>
###xml 482 484 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c24">24</xref>
###xml 664 666 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c37">37</xref>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 198 204 <span type="species:ncbi:9606">humans</span>
###xml 330 335 <span type="species:ncbi:10090">mouse</span>
###xml 376 382 <span type="species:ncbi:9606">humans</span>
###xml 410 415 <span type="species:ncbi:9606">human</span>
###xml 527 532 <span type="species:ncbi:10090">mouse</span>
###xml 594 599 <span type="species:ncbi:10090">mouse</span>
The conservation of transcription factor binding sites in the human and mouse CD36 promoters suggests that they are likely to be important in the regulation of CD36 gene expression in both mice and humans. The perfect conservation of the DR-1 element suggests that the PPARgamma:RXRalpha complex regulates CD36 gene expression in mouse macrophages by the same mechanism as in humans (36). The AML1 site in the human gene is required for constitutive promoter activity in monocytes (24) and conservation of this sequence in the mouse promoter also suggests that it has a similar function in the mouse. The binding sites for the ubiquitous transcription factor NF1 (37) could also be important in regulation of CD36 gene expression.
###end p 40
###begin p 41
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c21">21</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c38">38</xref>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 73 78 <span type="species:ncbi:9606">human</span>
###xml 145 150 <span type="species:ncbi:10090">mouse</span>
###xml 196 201 <span type="species:ncbi:9606">human</span>
###xml 274 279 <span type="species:ncbi:9606">human</span>
###xml 368 373 <span type="species:ncbi:9606">human</span>
###xml 407 412 <span type="species:ncbi:9606">human</span>
The consensus octamer site in the mouse promoter is not conserved in the human promoter. This correlates with the fact that CD36 is expressed in mouse primary B cells but has not been reported in human primary B cells (21). However, it is possible that CD36 is expressed in human B cells under some circumstances and that an Oct-2 binding site exists elsewhere in the human CD36 gene, as CD36 expression in human lymphoma cells has been reported (38).
###end p 41
###begin title 42
Oct-2-dependent transcription
###end title 42
###begin p 43
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c21">21</xref>
###xml 241 249 241 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 343 350 343 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c21">21</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse CD36 gene was the first gene to be identified as an Oct-2 target gene (21) and our finding that the promoter contains a consensus octamer site provides a molecular explanation for the Oct-2-dependent expression of CD36 in B cells. In vitro, this octamer site can recruit either Oct-1 or Oct-2, but B cell-specific expression of CD36 in vivo is critically dependent upon Oct-2 (21; this study). Our analysis of the CD36 promoter activity demonstrated that octamer-dependent transcription requires the expression of Oct-2 and that the endogenous Oct-1 was insufficient.
###end p 43
###begin title 44
OBF-1 is not required for CD36 transcription
###end title 44
###begin p 45
###xml 134 142 134 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">obf-1</italic>
###xml 200 203 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 465 469 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blr1</italic>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">obf-1</italic>
###xml 562 565 562 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c26">26</xref>
###xml 614 618 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blr1</italic>
###xml 880 881 880 881 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 922 923 922 923 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 964 966 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c13">13</xref>
###xml 967 969 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c14">14</xref>
###xml 1008 1009 1008 1009 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 1395 1400 1395 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 1400 1403 1400 1403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 1408 1413 1408 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">obf-1</italic>
###xml 1413 1416 1413 1416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 1569 1574 1569 1574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 1574 1577 1574 1577 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 608 613 <span type="species:ncbi:10090">mouse</span>
###xml 1417 1421 <span type="species:ncbi:10090">mice</span>
###xml 1578 1582 <span type="species:ncbi:10090">mice</span>
Our investigation of OBF-1 in the regulation of CD36 gene expression showed that Oct-2 is unable to recruit OBF-1 to the CD36 octamer in vitro and that expression of CD36 in primary B cells from obf-1-/- mice is unaffected. The regulation of CD36 transcription in B cells therefore appears to be dependent upon Oct-2 but not OBF-1, demonstrating that OBF-1 is not a prerequisite for transcriptional regulation by Oct-2. This is in contrast to the regulation of the blr1 gene whose promoter can be stimulated by OBF-1 and whose expression is >50% reduced in obf-1-/- B cells (26). The octamer sequence in the mouse blr1 gene is AAACAAAT and can presumably support Oct-2-dependent recruitment of OBF-1, although this has not been demonstrated. Other studies have shown that OBF-1 recruitment is dependent upon the presence of adenosine at position five in the octamer sequence (ATGCAAAT) and that mutation to a thymine (ATGCTAAT) prevents ternary complex formation (13,14). The CD36 octamer is of the type ATGCTAAT, suggesting that the presence of thymine at position 5 in the CD36 octamer discriminates between Oct-2 and an Oct factor/OBF-1 complex. It therefore appears that Oct-2 can specifically exclude OBF-1 from the regulation of some genes whilst actively recruiting it to regulate others, depending on the nature of the octamer. This is supported by a comparison of the phenotypes of the oct-2-/- and obf-1-/- mice, which both show severely reduced numbers of mature B cells and low levels of secondary antibody isotypes in serum. However, only B cells from the oct-2-/- mice are unable to proliferate normally when stimulated with anti-IgM or T cell-independent mitogens. Therefore, these overlapping, yet distinct, phenotypes support the idea that Oct-2 regulates gene expression by OBF-1-dependent and -independent mechanisms.
###end p 45
###begin title 46
A possible mechanism to evade Oct-1 regulation
###end title 46
###begin p 47
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c2">2</xref>
###xml 802 803 802 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf265c2">2</xref>
Members of a given transcription factor family often possess identical or overlapping DNA-binding specificities. Therefore, a complete understanding of transcription factor function must address the question of how transcription factors with the same DNA-binding specificity target different genes within the same cell. We have investigated how a single gene can be specifically regulated by the transcription factor Oct-2 but escapes the control of Oct-1, which has an identical DNA-binding specificity. Oct-1 is a weak activator of mRNA genes and therefore requires the presence of a co-activator to achieve efficient transcriptional activation (reviewed in 2). The fact that Oct-1 requires an additional co-activator such as VP16 or OBF-1 to stimulate transcription from mRNA promoters (reviewed in 2) suggests that exclusion of OBF-1 from the CD36 promoter by use of the ATGCTAAT sequence renders the CD36 gene refractory to Oct-1 transcriptional activation.
###end p 47
###begin p 48
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
In summary, our analysis of the mouse CD36 promoter has revealed that Oct-2 regulates the transcription of the CD36 gene by directly binding to an octamer site located in the promoter. The octamer sequence is of a type that excludes the recruitment of OBF-1 whilst maintaining high affinity Oct-2 binding, thus providing a possible mechanism to enable CD36 expression to evade Oct-1 regulation.
###end p 48
###begin title 49
Figures and Tables
###end title 49
###begin p 50
###xml 69 70 69 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 265 267 265 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ts</italic>
###xml 358 359 358 359 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
###xml 136 141 <span type="species:ncbi:9606">human</span>
###xml 238 243 <span type="species:ncbi:10090">mouse</span>
 Sequence alignment of the mouse and human CD36 proximal promoters. (A) The mouse CD36 5'-proximal promoter sequence is shown above the human sequence (23). Asterisks indicate identical nucleotides. Nucleotides corresponding to the known mouse cDNA are underlined. Ts denotes the transcription start sites. The transcription factor binding sites are boxed. (B) Agarose gel showing a single band of approximately125 bp from the 5'-RACE reaction (lane 1). The band was excised, cloned and 12 separate clones were sequenced.
###end p 50
###begin p 51
###xml 59 60 59 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 90 98 90 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 366 367 366 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 537 538 537 538 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 874 875 874 875 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
 Specific binding of Oct-1 and Oct-2 to the CD36 octamer. (A) Gel retardation analysis of in vitro translated Oct-1 and Oct-2, demonstrating specific binding to the octamer site within the CD36 promoter. Reactions were performed with either the wild-type CD36 probe (CD36, lanes 1-3), the mutant octamer CD36 probe (CD36mOct, lanes 4-6) or a known octamer element (VHOct, lanes 7-9). Reticulocyte lysates were programmed with cDNAs for the proteins indicated above each lane. Lanes 1, 4 and 7 contain unprogrammed reticulocyte lysates. (B) Gel retardation analysis showing the CD36 octamer (CD36 Oct) specifically competes with the IgK octamer (IgK Oct). Nuclear extracts from WEHI231 cells were incubated with radiolabelled IgK Oct in the presence of 100-fold molar excess of competitor DNA as indicated above the lanes. The known Oct-1 and Oct-2 complexes are indicated. (C) Oct-2 specifically binds to the CD36 octamer. Nuclear extracts from WEHI231 cells were incubated with radiolabelled CD36 Oct in the presence of 100-fold molar excess of competitor DNA as indicated above the lanes (lanes 2-4). Lanes 5 and 6 contain serum and Oct-2-specific antibody, respectively. The identity of each of the complexes is indicated.
###end p 51
###begin p 52
###xml 90 91 90 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 277 278 274 275 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 288 293 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 293 296 290 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
 Transcriptional activation of the CD36 promoter in Abl1.1 and Abl/Oct-2-ER pre-B cells. (A) Northern blot of endogenous CD36 mRNA from Abl/Oct-2-ER cells before and after beta-estradiol stimulation. Equal amounts of RNA were loaded; GAPDH mRNA is shown as a loading control. (B) Abl1.1 (oct-2-/-) or Abl/Oct-2-ER (Oct-2 inducible) cells were transfected with the luciferase reporter plasmid pGLCD36 or the control plasmid pGLB. Cells were left unstimulated (-) or stimulated by addition of 1 microM beta-estradiol (+). Luciferase activities were determined from triplicate experiments (means +/- standard errors) and are representative of several experiments performed in duplicate or triplicate.
###end p 52
###begin p 53
###xml 381 382 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
 Mutation of the octamer element blocks Oct-2-dependent activation in Abl1.1/Oct-2-ER cells. Graph showing fold activation of the wild-type CD36 promoter reporter, CD36, and the mutant derivative containing a mutated octamer site (mOct). Transfected cells were left unstimulated (-) or stimulated with 1 microM beta-estradiol (+). Luciferase activities (means +/- standard errors; n = 3) are shown as fold activation relative to the unstimulated sample, which was set to 1.
###end p 53
###begin p 54
###xml 66 67 66 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 199 200 199 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 492 493 492 493 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 517 522 517 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OBF-1</italic>
###xml 522 525 522 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 530 535 530 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 535 538 535 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 613 618 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OBF-1</italic>
###xml 618 621 618 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 625 630 625 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oct-2</italic>
###xml 630 633 630 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
 OBF-1 is not required for Oct-2-dependent CD36 gene expression. (A) Gel retardation analysis of the Oct-2 POU domain (POU-2) and OBF-1 on the CD36 promoter. Proteins were incubated with either the VHOct probe (lanes 1-4) or the CD36 probe (lanes 5-8). The identity of the proteins in the reaction is shown above each lane. Lanes 1 and 5 contain unprogrammed reticulocyte lysate. The positions of the free DNA, the binary complex (POU-2) and the ternary complex (POU-2/OBF-1) are indicated. (B) Expression of CD36 in OBF-1-/- and oct-2-/- splenic B cells. RT-PCR was performed using cDNAs derived from wild-type, OBF-1-/- or oct-2-/- splenic B cells. Each panel shows a titration of the RT-PCR products from each of the B cell samples. The RT-PCR product is indicated to the left of each panel and the genotype of the B cells is shown above each of the three lanes. The panel number referred to in the text is shown on the right.
###end p 54
###begin title 55
ACKNOWLEDGEMENTS
###end title 55
###begin p 56
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">obf-1</italic>
###xml 115 118 115 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
We thank H. Singh and W. Schaffner for providing plasmids. We also thank P. Matthias for kindly providing the obf-1-/- mice. This work was supported by the Wellcome Trust (P.S.) and the Australian National Health and Medical Research Council (L.M.C.)
###end p 56
###begin title 57
REFERENCES
###end title 57

